MICROCHIP TECHNOLOGY INC (MCHP): Results of Operations and Financial Condition
MICROCHIP TECHNOLOGY INC (MCHP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 NEWS RELEASE INVESTOR RELATIONS CONTACT: Sajid Daudi -- Head of Investor Relations..... (480) 792-7385 MICROCHIP TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2027 • Net sales of $1.485 billion, increased 38.0% from the year-ago quarter and
How this was made
The 30-second read
Why it matters
The key tradable elements are the reported Q1 financials versus prior-year and sequential comparisons, plus the explicit Q2 net sales and EPS/margin outlook that can shift consensus estimates and positioning.
Market read
A fresh earnings and guidance release for a major embedded semiconductor supplier, with explicit Q2 ranges for net sales, margins, and EPS.
What to watch
Non-GAAP excludes multiple items; traders may focus on whether GAAP profitability and cash generation sustain alongside margin expansion and net-debt reduction.
Net sales were $1.485 billion, up 38.0% year over year and 13.2% sequentially, while non-GAAP diluted net income per common share was $0.76.
Net sales exceeded the midpoint of prior guidance, GAAP and non-GAAP EPS exceeded the stated guidance ranges, profitability improved with higher factory utilization, and September-quarter guidance calls for further sequential sales growth and margin progress.
Actuals vs. the company’s prior outlook
from its previous release| Metric | Guided | Reported | Verdict |
|---|---|---|---|
| Net sales | The midpoint of our guidance provided on May 7, 2026 was net sales of $1.456 billion. | $1.485 billion | above |
| GAAP EPS per diluted share | $0.28 to $0.29 | $0.37 per diluted share | above |
| Non-GAAP EPS per diluted share | $0.67 to $0.71 | $0.76 per diluted share | above |
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net salesGAAP | $1.485 billion | 13.2% | 38.0% |
| Gross profitGAAP | $938.9 million | – | – |
| Gross marginGAAP | 63.2% | – | – |
| Operating incomeGAAP | $336.8 million | – | – |
| Operating marginGAAP | 22.7% of net sales | – | – |
| Other expenseGAAP | $(46.9) million | – | – |
| Income tax provisionGAAP | $60.1 million | – | – |
| Net incomeGAAP | $229.8 million | – | – |
| Dividends on Series A Preferred StockGAAP | $(27.8) million | – | – |
| Net income attributable to common stockholdersGAAP | $202.0 million | – | – |
| Net income attributable to common stockholders marginGAAP | 13.6% | – | – |
| Diluted net income per common shareGAAP | $0.37 per diluted share | – | – |
| Gross profitnon-GAAP | $947.6 million | – | – |
| Gross marginnon-GAAP | 63.8% | – | – |
| Operating incomenon-GAAP | $521.1 million | – | – |
| Operating marginnon-GAAP | 35.1% of net sales | – | – |
| Other expensenon-GAAP | $(46.9) million | – | – |
| Income tax provisionnon-GAAP | $35.6 million | – | – |
| Net incomenon-GAAP | $438.6 million | – | – |
| Net income attributable to common stockholdersnon-GAAP | $438.6 million | – | – |
| Net income attributable to common stockholders marginnon-GAAP | 29.5% | – | – |
| Diluted net income per common sharenon-GAAP | $0.76 per diluted share | – | – |
| Inventory daysother | 175 days | – | – |
| PCIe Gen6 connectivity design winsother | 12 programs exiting the June quarter | double sequentially | – |
| Book-to-bill ratioother | well above 1 | – | – |
Second Quarter Fiscal Year 2027 outlook
- Revenue$1.589 to $1.618 billion
- Gross marginGAAP gross profit: 65.4% to 66.3%; Non-GAAP gross profit: 66.0% to 67.0%
- Operating expensesGAAP: 37.3% to 37.4%; Non-GAAP: 27.5%
- NoteNon-GAAP gross-profit adjustments: $10.3 to $11.3 million
- NoteGAAP operating-expense adjustments: $155.7 to $159.7 million
- NoteGAAP operating income: 28.1% to 28.9%
- NoteNon-GAAP operating-income adjustments: $166.0 to $171.0 million
- NoteNon-GAAP operating income: 38.5% to 39.5%
- NoteGAAP other expense, net: $48.7 to $49.3 million
- NoteNon-GAAP adjustments to other expense, net: $(0.2) to $0.2 million
- NoteNon-GAAP other expense, net: $48.5 to $49.5 million
- NoteGAAP income tax provision: $75.3 to $96.5 million
- NoteNon-GAAP income-tax adjustments: $(52.2) to $(33.1) million
- NoteNon-GAAP income tax provision: $42.2 to $44.3 million
- NoteGAAP net income: $321.0 to $323.0 million
- NoteNon-GAAP net-income adjustments: $199.0 to $223.4 million
- NoteNon-GAAP net income: $520.0 to $546.4 million
- NoteGAAP dividends on Series A Preferred Stock: $(27.8) million
- NoteNon-GAAP adjustments for dividends on Series A Preferred Stock: $27.8 million
- NoteGAAP net income attributable to common stockholders: $293.2 to $295.2 million
- NoteNon-GAAP adjustments to net income attributable to common stockholders: $226.8 to $251.2 million
- NoteNon-GAAP net income attributable to common stockholders: $520.0 to $546.4 million
- NoteGAAP diluted common shares outstanding: Approximately 550.7 to 551.7 million shares
- NoteNon-GAAP adjustments to diluted common shares outstanding: 23.8 million shares
- NoteNon-GAAP diluted common shares outstanding: Approximately 574.5 to 575.5 million shares
- NoteGAAP diluted net income per common share: $0.53 to $0.54
- NoteNon-GAAP adjustments to diluted net income per common share: $0.38 to $0.41
- NoteNon-GAAP diluted net income per common share: $0.91 to $0.95
- NoteCapital expenditures for the quarter ending September 30, 2026: between $20 million and $25 million
- NoteCapital expenditures for all of fiscal 2027: approximately $100 million
- NoteNet sales for the September quarter are expected to be up sequentially between 7% and 9%
- NoteAt the midpoint, September-quarter net sales would represent year-over-year growth of approximately 40.6%
Capital returns
- Returned approximately $246.9 million to common stockholders in the June quarter through dividends.
- Quarterly cash dividend on common stock declared for the September quarter of 45.5 cents per share, payable on September 9, 2026 to stockholders of record on August 24, 2026.
- Quarterly cash dividend on Microchip's 7.50% Series A Mandatory Convertible Preferred Stock of $18.750 per share, which represents $0.9375 per depositary share, payable on September 15, 2026 to stockholders of record on September 1, 2026.
What drove it
- Improving demand.
- Continued inventory normalization.
- Stronger factory utilization.
- Lower underutilization charges.
- Disciplined expense management.
- Distribution sell-through increased meaningfully.
- Bookings remained strong with a book-to-bill ratio well above 1.
- Customer activity improved across several key end markets.
- PCIe Gen6 connectivity design wins doubled sequentially from six programs at the end of the March quarter to 12 programs exiting the June quarter.
Concerns
- The company described the macroeconomic environment in fiscal 2025 as slow and said it has paused most factory expansion actions and reduced planned capital investments through fiscal 2027.
- GAAP second-quarter operating-expense guidance excludes certain Special Charges and Other, net that may be recognized during the quarter ending September 30, 2026.
- GAAP guidance excludes potential gains or charges related to the ongoing evaluation of restructuring activities, including the sale of the Fab 2 wafer fabrication facility in Tempe, Arizona.
- GAAP tax-expense guidance excludes unexpected tax events that may occur during the quarter.
What to watch
- September-quarter net sales guidance of $1.589 to $1.618 billion and expected sequential growth of between 7% and 9%.
- Guided non-GAAP gross profit of 66.0% to 67.0% and non-GAAP operating income of 38.5% to 39.5%.
- Whether improving factory utilization and lower underutilization charges continue to support operating leverage.
- Inventory normalization, distribution sell-through, bookings activity, and the book-to-bill ratio.
- Expansion of PCIe Gen6 connectivity design wins and customer activity in data center and connectivity applications.
- Net-debt reduction and capital expenditures expected to be between $20 million and $25 million for the quarter ending September 30, 2026.
Balance sheet and cash flow
- Continued balance sheet deleveraging with approximately $170 million reduction in net debt during the June quarter.
- Inventory days declined from 185 days on March 31 to 175 days on June 30.
- Management cited meaningful sequential improvements in cash generation, but did not report an operating cash flow or free cash flow figure.
Analysis
Microchip opened fiscal 2027 with net sales of $1.485 billion, up 38.0% from $1.076 billion in the prior-year first fiscal quarter and up 13.2% sequentially. Sales were above the $1.456 billion midpoint of guidance provided on May 7, 2026. Management attributed the result to improving demand, inventory normalization, stronger factory utilization, increased distribution sell-through, strong bookings, and improved customer activity across several key end markets.
Profitability improved substantially. GAAP gross margin was 63.2%, GAAP operating income was $336.8 million, and GAAP diluted net income per common share was $0.37, compared with a GAAP net loss attributable to common stockholders of $46.4 million, or $0.09 per diluted share, in the prior-year first fiscal quarter. On a non-GAAP basis, gross margin was 63.8%, operating income was $521.1 million, and diluted net income per common share was $0.76, compared with $0.27 per diluted share in the prior-year first fiscal quarter. The company cited higher factory utilization, lower underutilization charges, and disciplined expense management as drivers of the profitability improvement.
Operational indicators also strengthened. Inventory days fell from 185 days on March 31 to 175 days on June 30. Management said bookings remained strong with a book-to-bill ratio well above 1, while PCIe Gen6 connectivity design wins doubled sequentially from six programs at the end of the March quarter to 12 programs exiting the June quarter. The company returned approximately $246.9 million to common stockholders through dividends and reduced net debt by approximately $170 million during the June quarter.
For the second quarter of fiscal 2027, Microchip guided net sales to $1.589 to $1.618 billion, with sequential sales growth expected to be between 7% and 9%. It guided GAAP gross profit to 65.4% to 66.3% and non-GAAP gross profit to 66.0% to 67.0%, alongside GAAP diluted net income per common share of $0.53 to $0.54 and non-GAAP diluted net income per common share of $0.91 to $0.95. The outlook anticipates additional progress in factory utilization and operational leverage, but GAAP guidance excludes certain potential special charges, unexpected tax events, and potential restructuring-related gains or charges.
Management, verbatim
We kicked off fiscal 2027 on a strong note, with net sales increasing 38% year over year and 13.2% sequentially to $1.485 billion, above the high end of our guidance.
Steve Sanghi, President and Chief Executive Officer
Our operational metrics strengthened during the quarter, with inventory days declining from 185 days on March 31 to 175 days on June 30 and non-GAAP gross margin expanding sequentially to 63.8%, above the high end of our guidance range.
Steve Sanghi, President and Chief Executive Officer
Our June quarter financial performance demonstrates the strength of our operating model and the significant leverage embedded in the business as revenue recovers.
Eric Bjornholt, Corporate Senior Vice President and Chief Financial Officer
Not in the filing
stated, not guessed- Segment revenue and segment-level growth figures were not reported.
- Prior-quarter dollar amounts for net sales, gross profit, operating income, net income, and EPS were not reported.
- Prior-year gross profit, gross margin, operating income, operating margin, tax provision, and operating-expense figures were not reported.
- Operating cash flow was not reported.
- Free cash flow was not reported.
- Cash and cash equivalents were not reported.
- Total debt and net-debt balance amounts were not reported.
- Share repurchases were not reported.
- A numeric prior-guidance range for gross margin was not reported.
- A quantitative tax-rate guidance figure was not reported.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
This is an SEC Form 8-K with Exhibit 99.1 reporting Microchip’s first quarter fiscal 2027 results and providing second quarter fiscal 2027 guidance.
Ticker impact
Microchip reported Q1 FY2027 results and guided Q2 net sales to $1.589 to $1.618 billion, with GAAP EPS and Non-GAAP EPS ranges.
Likely positive near-term bias if the market views the Q2 sequential growth and EPS ranges as credible versus expectations, with upside sensitivity to any beat on sales and margins.
The 8-K includes concrete Q1 results (net sales, GAAP and Non-GAAP EPS) and a detailed Q2 outlook table, which are direct inputs to valuation and positioning.
Market effects
Semiconductor embedded/MCU peers may see read-across from Microchip’s inventory normalization, factory utilization, and PCIe Gen6 design-win momentum.
Limited direct regional impact; primarily US-listed semiconductor sentiment.
Global data center and connectivity demand signals could influence broader embedded connectivity supply-chain expectations.
Counterpoint
Guidance could still be vulnerable if bookings or sell-through decelerate, since the outlook is based on current expectations and the quarter-to-quarter demand cycle can swing.
Key entities
- issuerMicrochip Technology Incorporated
Reports Q1 FY2027 results and declares dividends, while issuing Q2 FY2027 guidance.
- executiveSteve Sanghi
CEO quote emphasizing net sales strength, inventory normalization, and PCIe Gen6 design-win momentum.
- executiveEric Bjornholt
CFO quote highlighting factory utilization, expense discipline, and net-debt reduction.
